Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Hypervitaminosis A [see Warnings and Precautions (5.5)]
In late 2023, the FDA added more than a dozen peptides including both BPC-157 and thymosin alpha 1 to its list of substances that should not be compounded because the agency has identified potential significant safety risks. For BPC-157, the agency warned that the peptide could trigger an immune response
All doses, protocols and outcomes discussed below are described strictly as reported in the peer-reviewed and preclinical literature
By adhering to these practices, peptides can remain stable and functional for years, ensuring reliable experimental results
Reconstituted with bacteriostatic water, the solution should be refrigerated at 2-8C
Assumption of Responsibility The purchaser is responsible for evaluating product suitability for a proposed lawful research protocol and for all risks arising from possession, handling, storage, experimental use, transfer, and disposal
US$ 23.59
US$ 25.06
US$ 20.67
.webp)
US$ 25.58
